Buy Eidos Therapeutics Inc Stock | EIDX Stock Price & Latest News | Public
EIDX

Eidos Therapeutics Inc

$0.00 (0.00%)Today

    About EIDX

    Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment w...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.26
    -0.53
    -0.79
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.78

    Actual EPS
    Q4 2020

    Stats

    Market Cap$3,55B
    Volume6,52k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$94.41
    1 Year Low$28.39
    Open$92.91
    High$95.91
    Low$92.91

    Buy any stock with any amount of money.

    Download the App
    Download the app